Merck KGaA, Darmstadt, Germany and Broad Institute Announce CRISPR License Framework to Encourage Innovation

18 JUL 2019 | DARMSTADT, GERMANY New framework simplifies and accelerates access to CRISPR intellectual property for research Merck KGaA, Darmstadt, Germany, a leading science and technology company, and the Broad Institute of MIT and Harvard today announced an agreement between Broad Institute and the Life Science business of Merck KGaA, Darmstadt, Germany to offer non-exclusive licenses... Read more

Oxford Nanopore prevails for fourth time in patent hearing

Wed 17th July 2019 Oxford Nanopore has prevailed once again following the decision yesterday by the European Patent Office (EPO) to revoke a second PacBio European Patent, EP3170904. This decision is consistent with that of an earlier EPO decisionrevoking PacBio European Patent EP3045542, as well as rulings from the ITC and US Court of Appeal that the claims of the... Read more

IDT and Washington University join forces to increase access to the latest NGS technologies

Jul 17, 2019 Preferred provider program pools expertise to deliver highest-quality sequencing data, even for challenging projects CORALVILLE, IA (July 17, 2019) – As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies. In line with this mission, the company has launched... Read more

Ontera Welcomes Dr. J. Wallace Parce to Its Advisory Board

July 17, 2019 07:30 AM Eastern Daylight Time SANTA CRUZ, Calif.–(BUSINESS WIRE)–Ontera, the leader in silicon-based nanopore diagnostics, today announced the appointment of Dr. J. Wallace (Wally) Parce to its Advisory Board. Dr. Parce comes to Ontera as a respected and successful serial entrepreneur in life science technology development and commercialization. He was Co-Founder, Vice... Read more

Illumina Expands Genomics Accelerator to Cambridge, UK

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced the global expansion of Illumina Accelerator to Cambridge, United Kingdom. Founded in the San Francisco Bay Area in 2014, Illumina Accelerator is a company creation engine focused on partnering with entrepreneurs to build breakthrough genomics startups. Illumina Accelerator is proud to open its first international location at... Read more

PerkinElmer Launches CE-Marked Infectious Disease Immunoassays on EUROIMMUN Random Access Instrument

ChLIA-based tests for detection of antibodies against Borrelia and Epstein-Barr Virus now available on EUROIMMUN RA Analyzer 10 System WALTHAM, Mass. – July 10, 2019 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the first two CE-marked chemiluminescence immunoassays (ChLIA) for the detection of anti-Borrelia (Lyme disease) and... Read more

Introducing Three New Formats for Antimicrobial Susceptibility Testing, Including New Compounds for Combatting Gram Negative and Multidrug-Resistant Infections

Introducing Three New Formats for Antimicrobial Susceptibility Testing, Including New Compounds for Combatting Gram Negative and Multidrug-Resistant Infections New microbroth dilution plates provide gold standard-level(1) minimum inhibitory concentration (MIC) accuracy using first- and second-line treatment options LENEXA, Kan., July 10, 2019 /PRNewswire/ — Comprehensive antimicrobial susceptibility testing (AST) for Gram negative and multidrug-resistant organisms (MDRO),... Read more

FBI Approves Thermo Fisher Scientific Forensic Sequencing Solution for National DNA Index System

FBI Approves Thermo Fisher Scientific Forensic Sequencing Solution for National DNA Index System Decision enables human identification labs to upload genetic profiles to national database using Applied Biosystems Precision ID panel for mitochondrial DNA analysis SAN FRANCISCO, July 9, 2019 /PRNewswire/ — The U.S. Federal Bureau of Investigation (FBI) has approved Thermo Fisher Scientific’s Applied Biosystems... Read more

Scale-up: Oxford Nanopore’s new high-tech factory comes online

Mon 8th July 2019 8th July 2019, Oxford, UK: Oxford Nanopore has started high-tech, automated manufacturing processes at its new factory in Oxford, UK. The MinION building is a bespoke, state-of-the-art, high-tech manufacturing facility that brings new, highly automated production processes to the manufacturing of consumable flow cells for Oxford Nanopore’s novel, real-time DNA/RNA sequencing... Read more